Termin:
08.11.2010
18:00
Genomics, Demographics, Epidemics, Economics and Ethics
The Complex Forces Shaping Therapeutic Innovation and Investment
George Poste (Arizona State University)
Chief Scientist, Complex Adaptive Systems Initiative (CASI) and Del E. Webb Professor of Health Innovation at Arizona State University (ASU). He assumed this post in 2009. From 2003 to 2009 he directed and built the Biodesign Institute at ASU. In addition to his academic post he serves on the Board of Directors of Monsanto, Exelixis, Caris Life Sciences and the Scientific Advisory Board of Synthetic Genomics. From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham (SB). During his tenure at SB he was associated with the successful registration of 31 drug, vaccine and diagnostic products. In 2004 he was named as "R&D Scientist of the Year" by R&D Magazine, in 2006 he received the Einstein award from the Global Business Leadership Council and in 2009 received the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry. He has published over 350 research papers and edited 14 books on pharmaceutical technologies and oncology. He has received honorary degrees in science, law and medicine for his research contributions and was honored in 1999 by HM Queen Elizabeth II as a Commander of the British Empire for his contributions to international security. He is a Fellow of the UK Royal Society, the Royal College of Pathologists and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University, a member of the Council for Foreign Relations and the US Institute of Medicine Forum on Microbial Threats. He also serves on several US government panels related to biosecurity and national competitiveness.
Anmeldung erbeten!
Weitere Informationen
Kontakt:
Eva Schweng
CeMM - Forschungszentrum für Molekulare Medizin
Österreichische Akademie der Wissenschaften (ÖAW)
T +43 1 40160-70051